Clinical Trial Update: To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of ivabradine for stable, symptomatic chronic angina. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Xintong Pharmacy Company | Conditions: Angina Pectoris | Phase 2 | Status: UNKNOWN